{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2-Oxo-1,2-dihydroquinoline", "2-Oxoindoline", "Apoptosis", "Thiazolidine-2,4-dione", "VEGFR-2 inhibitors", "anticancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35801403", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "11"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2022.2085693"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "37", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: <i>in-vitro</i> anticancer evaluation and <i>in-silico</i> studies.", "Pagination": {"StartPage": "1903", "EndPage": "1917", "MedlinePgn": "1903-1917"}, "Abstract": {"AbstractText": ["A thiazolidine-2,4-dione nucleus was molecularly hybridised with the effective antitumor moieties; 2-oxo-1,2-dihydroquinoline and 2-oxoindoline to obtain new hybrids with potential activity against VEGFR-2. The cytotoxic effects of the synthesised derivatives against Caco-2, HepG-2, and MDA-MB-231 cell lines were investigated. Compound <b>12a</b> was found to be the most potent candidate against the investigated cell lines with IC<sub>50</sub> values of 2, 10, and 40\u2009\u00b5M, respectively. Furthermore, the synthesised derivatives were tested <i>in\u00a0vitro</i> for their VEGFR-2 inhibitory activity showing strong inhibition. Moreover, an <i>in\u00a0vitro</i> viability study against Vero non-cancerous cell line was investigated and the results reflected a high safety profile of all tested compounds. Compound <b>12a</b> was further investigated for its apoptotic behaviour by assessing the gene expression of four genes (Bcl2, Bcl-xl, TGF, and Survivin). Molecular dynamic simulations authenticated the high affinity, accurate binding, and perfect dynamics of compound <b>12a</b> against VEGFR-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Taghour", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt."}, {"Identifier": [], "Affiliation": "School of Biotechnology, Badr University in Cairo, Badr City, Cairo, Egypt."}], "LastName": "Eldehna", "ForeName": "Wagdy M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "El-Deeb", "ForeName": "Nehal M", "Initials": "NM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nucleic Acids Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "Kenawy", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxindoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazolidines"}, {"RegistryNumber": "0S9338U62H", "NameOfSubstance": "2-oxindole"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Vascular Endothelial Growth Factor Receptor-2"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Caco-2 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Oxindoles"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Thiazolidines"}, {"QualifierName": [], "DescriptorName": "Vascular Endothelial Growth Factor Receptor-2"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abd El-Mageed MM, Eissa AA, Farag AE-S, Osman EEA.. Design and synthesis of novel furan, furo [2, 3-d] pyrimidine and furo [3, 2-e][1, 2, 4] triazolo [1, 5-c] pyrimidine derivatives as potential VEGFR-2 inhibitors. Bioorg Chem 2021;116:105336.", "ArticleIdList": ["34530235"]}, {"Citation": "El-Sayed AA, Nossier ES, Almehizia AA, Amr AE-GE.. Design, synthesis, anticancer evaluation and molecular docking study of novel 2, 4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring systems as potential CDK-2 inhibitors. J Mol Struct 2022;1247:131285."}, {"Citation": "Chaudhari P, Bari S, Surana S, et al. . Logical synthetic strategies and structure-activity relationship of indolin-2-one hybrids as small molecule anticancer agents: an overview. J Mol Struct 2022;1247:131280."}, {"Citation": "Parmar DR, Soni JY, Guduru R, et al. . Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in\u00a0vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg Chem 2021;115:105206.", "ArticleIdList": ["34339975"]}, {"Citation": "Alsaif NA, Taghour MS, Alanazi MM, et al. . Identification of new [1, 2, 4] triazolo [4, 3-a] quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: design, synthesis, anticancer evaluation, and in silico studies. Bioorg Med Chem 2021;46:116384.", "ArticleIdList": ["34479065"]}, {"Citation": "Elrazaz EZ, Serya RA, Ismail NS, et al. . Discovery of potent thieno [2, 3-d] pyrimidine VEGFR-2 inhibitors: design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorg Chem 2021;113:105019.", "ArticleIdList": ["34091286"]}, {"Citation": "Mohamed TK, Batran RZ, Elseginy SA, et al. . Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorg Chem 2019;85:253\u201373.", "ArticleIdList": ["30641320"]}, {"Citation": "Mahdy HA, Ibrahim MK, Metwaly AM, et al. . Design, synthesis, molecular modeling, in\u00a0vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Bioorg Chem 2020;94:103422.", "ArticleIdList": ["31812261"]}, {"Citation": "Guo S, Colbert LS, McGlothen TZ, Gonzalez-Perez RR.. Regulation of angiogenesis in human cancer via vascular endothelial growth factor receptor-2 (VEGFR-2). Tumor Angiogenesis 2012;2012:27\u201366."}, {"Citation": "Modi SJ, Kulkarni VM.. Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective. Med Drug Discovery 2019;2:100009."}, {"Citation": "Huang Y, Chen X, Dikov MM, et al. . Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood J Am Soc Hematol 2007;110:624\u201331.", "ArticleIdList": ["PMC1924481", "17376891"]}, {"Citation": "Machado VA, Peixoto D, Costa R, et al. . Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno [3, 2-b] pyridin-7-ylthio) phenyl] ureas: discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors. Bioorg Med Chem 2015;23:6497\u2013509.", "ArticleIdList": ["26344591"]}, {"Citation": "Wang Z, Wang N, Han S, et al. . Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One 2013;8:e68566.", "ArticleIdList": ["PMC3702614", "23861918"]}, {"Citation": "Dietrich J, Hulme C, Hurley LH.. The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec\u00ae, Nexavar\u00ae, and BIRB-796. Bioorg Med Chem 2010;18:5738\u201348.", "ArticleIdList": ["20621496"]}, {"Citation": "Xie Q-Q, Xie H-Z, Ren J-X, et al. . Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2. J Mol Graph Model 2009;27:751\u20138.", "ArticleIdList": ["19138543"]}, {"Citation": "Lee K, Jeong K-W, Lee Y, et al. . Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. Eur J Med Chem 2010;45:5420\u20137.", "ArticleIdList": ["20869793"]}, {"Citation": "Eskander RN, Tewari KS.. Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma\u2014mechanistics, review of phase III randomized clinical trials, and regulatory implications. Gynecol Oncol 2014;132:496\u2013505.", "ArticleIdList": ["24316305"]}, {"Citation": "Abdel-Aziz HA, Ghabbour HA, Eldehna WM, et al. . Synthesis, crystal structure, and biological activity of cis/trans amide rotomers of (Z)-N\u2032-(2-Oxoindolin-3-ylidene) formohydrazide. J Chem 2014;2014:1\u20137."}, {"Citation": "Eldehna WM, Al-Wabli RI, Almutairi MS, et al. . Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents. J Enzyme Inhib Med Chem 2018;33:867\u201378.", "ArticleIdList": ["PMC7011955", "29707975"]}, {"Citation": "Attia MI, Eldehna WM, Afifi SA, et al. . New hydrazonoindolin-2-ones: synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres. PloS One 2017;12:e0181241.", "ArticleIdList": ["PMC5526551", "28742842"]}, {"Citation": "Mohamady S, Galal M, Eldehna WM, et al. . Dual targeting of VEGFR2 and C-met kinases via the design and synthesis of substituted 3-(Triazolo-thiadiazin-3-yl) indolin-2-one derivatives as angiogenesis inhibitors. ACS Omega 2020;5:18872\u201386.", "ArticleIdList": ["PMC7408256", "32775889"]}, {"Citation": "Eldehna WM, Abo-Ashour MF, Al-Warhi T, et al. . Development of 2-oxindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells. J Enzyme Inhib Med Chem 2021;36:320\u20139.", "ArticleIdList": ["PMC7751403", "33345633"]}, {"Citation": "Prakash CR, Raja S.. Indolinones as promising scaffold as kinase inhibitors: a review. Mini Rev Med Chem 2012;12:98\u2013119.", "ArticleIdList": ["22372601"]}, {"Citation": "Zou H, Zhang L, Ouyang J, et al. . Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents. Eur J Med Chem 2011;46:5970\u20137.", "ArticleIdList": ["22019188"]}, {"Citation": "Fang Y, Wu Z, Xiao M, et al. . Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents. Bioorg Chem 2021;106:104469.", "ArticleIdList": ["33239239"]}, {"Citation": "Bonnefous C, Payne JE, Roppe J, et al. . Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. J Med Chem 2009;52:3047\u201362.", "ArticleIdList": ["19374401"]}, {"Citation": "Ohashi T, Oguro Y, Tanaka T, et al. . Discovery of pyrrolo [3, 2-c] quinoline-4-one derivatives as novel hedgehog signaling inhibitors. Bioorg Med Chem 2012;20:5496\u2013506.", "ArticleIdList": ["22910224"]}, {"Citation": "Suthar SK, Jaiswal V, Lohan S, et al. . Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening. Eur J Med Chem 2013;63:589\u2013602.", "ArticleIdList": ["23548704"]}, {"Citation": "Banu S, Bollu R, Bantu R, et al. . Design, synthesis and docking studies of novel 1, 2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents. Eur J Med Chem 2017;125:400\u201310.", "ArticleIdList": ["27688193"]}, {"Citation": "Yu Y-C, Kuang W-B, Huang R-Z, et al. . Design, synthesis and pharmacological evaluation of new 2-oxo-quinoline derivatives containing \u03b1-aminophosphonates as potential antitumor agents. MedChemComm 2017;8:1158\u201372.", "ArticleIdList": ["PMC6072518", "30108826"]}, {"Citation": "Shankar S, Vuppu S.. In vitro drug metabolism and pharmacokinetics of a novel thiazolidinedione derivative, a potential anticancer compound. J Pharma Biomed Anal 2020;179:113000.", "ArticleIdList": ["31787460"]}, {"Citation": "Sharma P, Reddy TS, Kumar NP, et al. . Conventional and microwave-assisted synthesis of new 1H-benzimidazole-thiazolidinedione derivatives: a potential anticancer scaffold. Eur J Med Chem 2017;138:234\u201345.", "ArticleIdList": ["28668476"]}, {"Citation": "Joshi H, Patil V, Tilekar K, et al. . Benzylidene thiazolidinediones: synthesis, in\u00a0vitro investigations of antiproliferative mechanisms and in\u00a0vivo efficacy determination in combination with Imatinib. Bioorg Med Chem Lett 2020;30:127561.", "ArticleIdList": ["32961322"]}, {"Citation": "Alsaif NA, Taghour MS, Alanazi MM, et al. . Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2032, 4\u2032-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J Enzyme Inhib Med Chem 2021;36:1093\u2013114.", "ArticleIdList": ["PMC8168755", "34056992"]}, {"Citation": "Alanazi MM, Eissa IH, Alsaif NA, et al. . Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J Enzyme Inhib Med Chem 2021;36:1760\u201382.", "ArticleIdList": ["PMC8344243", "34340610"]}, {"Citation": "Abdallah AE, Alesawy MS, Eissa SI, et al. . Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: molecular modeling and in\u00a0vitro antiviral screening. New J Chem 2021;45:16557\u201371."}, {"Citation": "Alanazi MM, Elkady H, Alsaif NA, et al. . New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv 2021;11:30315\u201328.", "ArticleIdList": ["PMC9044819", "35493991"]}, {"Citation": "Alsaif NA, Dahab MA, Alanazi MM, et al. . New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: design, molecular modeling, and synthesis. Bioorg Chem 2021;110:104807.", "ArticleIdList": ["33721808"]}, {"Citation": "El-Metwally SA, Abou-El-Regal MM, Eissa IH, et al. . Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg Chem 2021;112:104947.", "ArticleIdList": ["33964580"]}, {"Citation": "Alanazi MM, Elkady H, Alsaif NA, et al. . Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: design, synthesis, and in silico study. J Mol Struct 2022;1253:132220."}, {"Citation": "Elkady H, Elwan A, El-Mahdy HA, et al. . New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. J Enzyme Inhib Med Chem 2022;37:397\u2013410.", "ArticleIdList": ["PMC8725875", "34961427"]}, {"Citation": "El-Zahabi MA, Sakr H, El-Adl K, et al. . Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorg Chem 2020;104:104218.", "ArticleIdList": ["32932121"]}, {"Citation": "Laxmikeshav K, Kumari P, Shankaraiah N.. Expedition of sulfur\u2010containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: a decade update. Med Res Rev 2022;42:513\u201375.", "ArticleIdList": ["34453452"]}, {"Citation": "Yadav U, Vanjari Y, Laxmikeshav K, et al. . Synthesis and in\u00a0vitro cytotoxicity evaluation of phenanthrene linked 2, 4-thiazolidinediones as potential anticancer agents. Anti-Cancer Agents Med Chem 2021;21:1127\u201340.", "ArticleIdList": ["32664846"]}, {"Citation": "Tokala R, Thatikonda S, Sana S, et al. . Synthesis and in\u00a0vitro cytotoxicity evaluation of \u03b2-carboline-linked 2, 4-thiazolidinedione hybrids: potential DNA intercalation and apoptosis-inducing studies. New J Chem 2018;42: 16226\u201336."}, {"Citation": "Sharma P, Reddy TS, Thummuri D, et al. . Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents. Eur J Med Chem 2016;124:608\u201321.", "ArticleIdList": ["27614408"]}, {"Citation": "Hou T, Zhu L, Chen L, Xu X.. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. J Chem Inform Comput Sci 2003;43:273\u201387.", "ArticleIdList": ["12546563"]}, {"Citation": "Kar K, Krithika U, Basu P, et al. . Design, synthesis and glucose uptake activity of some novel glitazones. Bioorg Chem 2014;56:27\u201333.", "ArticleIdList": ["24927033"]}, {"Citation": "Abdel-Wahab BF, Khidre RE.. 2-Chloroquinoline-3-carbaldehyde II: synthesis, reactions, and applications. J Chem 2013;2013:1\u201313."}, {"Citation": "Bruno G, Costantino L, Curinga C, et al. . Synthesis and aldose reductase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones. Bioorg Med Chem 2002;10:1077\u201384.", "ArticleIdList": ["11836118"]}, {"Citation": "Evdokimov NM, Magedov IV, McBrayer D, Kornienko A.. Isatin derivatives with activity against apoptosis-resistant cancer cells. Bioorg Med Chem Lett 2016;26:1558\u201360.", "ArticleIdList": ["PMC4775416", "26883150"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Denizot F, Lang R.. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271\u20137.", "ArticleIdList": ["3486233"]}, {"Citation": "Thabrew M, Hughes RD, Mcfarlane IG.. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J Pharm Pharmacol 2011;49:1132\u20135.", "ArticleIdList": ["9401951"]}, {"Citation": "Pritchett JC, Naesens L, Montoya J. Treating HHV-6 infections: the laboratory efficacy and clinical use of ati-HHV-6 agents. 7th edition; 2014. Pages 311\u2013331."}, {"Citation": "Pe\u00f1a-Mor\u00e1n OA, Villarreal ML, \u00c1lvarez-Berber L, et al. . Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines. Molecules 2016;21:1013.", "ArticleIdList": ["PMC6274026", "27527135"]}, {"Citation": "Indrayanto G, Putra GS, Suhud F.. Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Subst Excip Related Methodol 2021;46:273\u2013307.", "ArticleIdList": ["33461699"]}, {"Citation": "Liang C-C, Park AY, Guan J-L.. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in\u00a0vitro. Nature Protocols 2007;2:329\u201333.", "ArticleIdList": ["17406593"]}, {"Citation": "D\u2019Anselmi F, Valerio M, Cucina A, et al. . Metabolism and cell shape in cancer: a fractal analysis. Int J Biochem Cell Biol 2011;43:1052\u20138.", "ArticleIdList": ["20460170"]}, {"Citation": "Kim R. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem Biophys Res Commun 2005;333:336\u201343.", "ArticleIdList": ["15922292"]}, {"Citation": "Yang J, Song K, Krebs TL, et al. . Rb/E2F4 and Smad2/3\u2009link survivin to TGF-\u03b2-induced apoptosis and tumor progression. Oncogene 2008;27:5326\u201338.", "ArticleIdList": ["PMC2762862", "18504435"]}, {"Citation": "El-Helby A-GA, Ayyad RR, El-Adl K, Elkady H.. Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Mol Divers 2019;23:283\u201398.", "ArticleIdList": ["30168051"]}, {"Citation": "El\u2010Helby AGA, Ayyad RR, Zayed MF, et al. . Design, synthesis, in silico ADMET profile and GABA\u2010A docking of novel phthalazines as potent anticonvulsants. Archiv Der Pharmazie 2019;352:1800387.", "ArticleIdList": ["30989729"]}, {"Citation": "Sousa SF, Fernandes PA, Ramos MJ.. Protein\u2013ligand docking: current status and future challenges. Proteins: Struct Funct Bioinform 2006;65:15\u201326.", "ArticleIdList": ["16862531"]}, {"Citation": "Hollingsworth SA, Dror RO.. Molecular dynamics simulation for all. Neuron 2018;99:1129\u201343.", "ArticleIdList": ["PMC6209097", "30236283"]}, {"Citation": "Hansson T, Oostenbrink C, van Gunsteren W.. Molecular dynamics simulations. Curr Opin Struct Biol 2002;12:190\u20136.", "ArticleIdList": ["11959496"]}, {"Citation": "Durrant JD, McCammon JA.. Molecular dynamics simulations and drug discovery. BMC Biol 2011;9:71\u20139.", "ArticleIdList": ["PMC3203851", "22035460"]}, {"Citation": "Miller BR, III, McGee TD, Jr, Swails JM, et al. . MMPBSA. PY: an efficient program for end-state free energy calculations. J Chem Theory Comput 2012;8:3314\u201321.", "ArticleIdList": ["26605738"]}, {"Citation": "Wang E, Sun H, Wang J, et al. . End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design. Chem Rev 2019;119:9478\u2013508.", "ArticleIdList": ["31244000"]}, {"Citation": "Genheden S, Ryde U.. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015;10:449\u201361.", "ArticleIdList": ["PMC4487606", "25835573"]}, {"Citation": "Hou T, Wang J, Li Y, Wang W.. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Informat Model 2011;51:69\u201382.", "ArticleIdList": ["PMC3029230", "21117705"]}, {"Citation": "Xia X, Maliski EG, Gallant P, Rogers D.. Classification of kinase inhibitors using a Bayesian model. J Med Chem 2004;47:4463\u201370.", "ArticleIdList": ["15317458"]}, {"Citation": "BIOVIA QSAR, ADMET and predictive toxicology. https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html [last accessed May 2020]."}, {"Citation": "El-Deeb NM, Ibrahim OM, Mohamed MA, et al. . Alginate/\u03ba-carrageenan oral microcapsules loaded with Agaricus bisporus polysaccharides MH751906 for natural killer cells mediated colon cancer immunotherapy. Int J Biol Macromol 2022;205:385\u201395.", "ArticleIdList": ["35183600"]}, {"Citation": "Abou-Seri SM, Eldehna WM, Ali MM, Abou El Ella DA.. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in\u00a0vitro biological evaluation. Eur J Med Chem 2016;107:165\u201379.", "ArticleIdList": ["26590508"]}, {"Citation": "Borenfreund E, Puerner JA.. Toxicity determined in\u00a0vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985;24:119\u201324.", "ArticleIdList": ["3983963"]}, {"Citation": "Koch A, Tamez P, Pezzuto J, Soejarto D.. Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. J Ethnopharmacol 2005;101:95\u201399.", "ArticleIdList": ["15878245"]}, {"Citation": "Arranz-Valsero I, Soriano-Roman\u00ed L, Garc\u00eda-Posadas L, et al. . IL-6 as a corneal wound healing mediator in an in\u00a0vitro scratch assay. Exp Eye Res 2014;125:183\u201392.", "ArticleIdList": ["24971496"]}, {"Citation": "Zucchini N, de Sousa G, Bailly-Maitre B, et al. . Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 2005;1745:48\u201358.", "ArticleIdList": ["16085054"]}, {"Citation": "El-Zahabi MA, Elbendary ER, Bamanie FH, et al. . Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists. Bioorg Chem 2019;91:103115.", "ArticleIdList": ["31310882"]}, {"Citation": "Ibrahim MK, Eissa IH, Alesawy MS, et al. . Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Bioorg Med Chem 2017;25:4723\u201344.", "ArticleIdList": ["28720328"]}, {"Citation": "Ibrahim MK, Eissa IH, Abdallah AE, et al. . Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists. Biorg Med Chem 2017;25:1496\u2013513.", "ArticleIdList": ["28117121"]}, {"Citation": "El-Gamal KM, El-Morsy AM, Saad AM, et al. . Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J Mol Struct 2018;1166:15\u201333."}, {"Citation": "Elkaeed EB, Elkady H, Belal A, et al. . Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent rna polymerase inhibitors among 3009 clinical and FDA-approved related drugs. Processes 2022;10:530."}, {"Citation": "Jo S, Kim T, Iyer VG, Im W.. CHARMM-GUI: a web-based graphical user interface for Charmm. J Comput Chem 2008;29:1859\u201365.", "ArticleIdList": ["18351591"]}, {"Citation": "Brooks BR, Brooks CL, III, Mackerell AD, Jr, et al. . CHARMM: the biomolecular simulation program. J Comput Chem 2009;30:1545\u2013614.", "ArticleIdList": ["PMC2810661", "19444816"]}, {"Citation": "Lee J, Cheng X, Swails JM, et al. . CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 2016;12:405\u201313.", "ArticleIdList": ["PMC4712441", "26631602"]}, {"Citation": "Best RB, Zhu X, Shim J, et al. . Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J Chem Theory Comput 2012;8:3257\u201373.", "ArticleIdList": ["PMC3549273", "23341755"]}, {"Citation": "Phillips JC, Braun R, Wang W, et al. . Scalable molecular dynamics with NAMD. J Computat Chem 2005;26:1781\u2013802.", "ArticleIdList": ["PMC2486339", "16222654"]}, {"Citation": "Suleimen YM, Jose RA, Suleimen RN, et al. . Jusanin, a new flavonoid from Artemisia commutata with an in silico inhibitory potential against the SARS-CoV-2 main protease. Molecules 2022;27:1636.", "ArticleIdList": ["PMC8911936", "35268738"]}, {"Citation": "Suleimen YM, Jose RA, Suleimen RN, et al. . Isolation and in silico anti-SARS-CoV-2 Papain-like protease potentialities of two rare 2-phenoxychromone derivatives from Artemisia spp. Molecules 2022;27:1216.", "ArticleIdList": ["PMC8879996", "35209006"]}, {"Citation": "Mohammed SO, El Ashry ESH, Khalid A, et al. . Expression, purification, and comparative inhibition of helicobacter pylori urease by regio-selectively alkylated benzimidazole 2-thione derivatives. Molecules 2022;27:865.", "ArticleIdList": ["PMC8838460", "35164122"]}, {"Citation": "Alesawy MS, Elkaeed EB, Alsfouk AA, et al. . In silico screening of semi-synthesized compounds as potential inhibitors for SARS-CoV-2 papain-like protease: pharmacophoric features, molecular docking, ADMET, toxicity and DFT studies. Molecules 2021;26:6593.", "ArticleIdList": ["PMC8588135", "34771004"]}, {"Citation": "El-Adl K, Ibrahim M-K, Alesawy MS, Eissa IH.. [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4\u2032, 3\u2032-c] quinazoline derived DNA intercalators: design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorg Med Chem 2021;30:115958.", "ArticleIdList": ["33360576"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "8", "Hour": "4", "Minute": "32"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35801403", "PMC9272924", "10.1080/14756366.2022.2085693"]}}], "PubmedBookArticle": []}